BDBM663127 US20240109898, Compound Z-42::US20240109898, Compound Z-70

SMILES N[C@H]1CC[C@@H](C1)Nc1cc(nc2ccnn12)C(F)C1CCC1

InChI Key InChIKey=VYNHLDOOJDAYEV-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 663127   

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663127(US20240109898, Compound Z-42 | US20240109898, Comp...)
Affinity DataIC50: 22nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663127(US20240109898, Compound Z-42 | US20240109898, Comp...)
Affinity DataIC50: 23nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663127(US20240109898, Compound Z-42 | US20240109898, Comp...)
Affinity DataIC50: 3.30E+3nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663127(US20240109898, Compound Z-42 | US20240109898, Comp...)
Affinity DataIC50: 8.50E+3nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663127(US20240109898, Compound Z-42 | US20240109898, Comp...)
Affinity DataIC50: 2.26E+3nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Shanghai Haiyan Pharmaceutical Technology Co.

US Patent
LigandPNGBDBM663127(US20240109898, Compound Z-42 | US20240109898, Comp...)
Affinity DataIC50: 3.88E+3nMAssay Description:The inhibiting effects on the kinase activity of CDK1/CycB (Carna bioscience, #04-102), CDK2/CycA (Carna bioscience, #04-103) and CDK9/CycT (Carna bi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
Go to US Patent